Treatment of Pediatric IgG4-Related Orbital Disease With TNF-α Inhibitor

    loading  Checking for direct PDF access through Ovid

Abstract

The authors describe a 9-year-old female who presented with swelling, proptosis, and tenderness of the right upper eyelid and MRI imaging demonstrating right lacrimal gland enlargement. After failing treatment with corticosteroids, the patient underwent a biopsy that was consistent with IgG4-related orbital disease. She was subsequently successfully treated with adalimumab (TNF-α inhibitor). This is the first case report of the successful use of a TNF-α inhibitor for the treatment of IgG4-related orbital disease in a child.

Related Topics

    loading  Loading Related Articles